Sample pretreatment and immunoassay in a single workflow

		Reduce hands-on time: fewer manual steps
		Shorten overall run times: results in <1 hour
		Save precious reagents and samples by working at nanoliter scale
		Streamline workflow from development through screening to confirmation: supported by an assay protocol, Rexxip ADA buffer and Gyrolab ADA Software

See what happens inside a Gyrolab ADA CD

Video requires Flash 9.0.0

One microstructure:one data point:no cross-talk

		Minimize sample and reagent consumption - nanoliter volumes (200 nL)
		Short incubation times - fast reactions at nanoliter scale
		Consistent performance - samples processed simultaneously

Reproducible and precise

Parallel processing with precise control of mixing and incubation times ensure consistent assay performance.

Data demonstrates precision within and between runs for ADA control samples in 10% human matrix

Drug tolerance exceeds current recommendations

Sensitivity 160 ng/mL ADA in presence of 160 μg/mL free drug

Drug analog: recombinant hlgG1 to HIV-1 gp120, positive control: mlgG to HIV-1 gp120 antibody. %recovery = (+drug/-drug) x100 for each positive control level.